Variability and Advancements in ChatGPT Risk of Bias Assessments: A Replication and Comparative Analysis

Jules Descamps; Matthieu Resche-Rigon; Guillaume Draznieks; Cesar Quirino; Rémy Nizard; Pierre-Alban Bouché

doi:10.1111/jebm.70046

Journal of Evidence-Based Medicine ›› 2025, Vol. 18 ›› Issue (2) : e70046 DOI: 10.1111/jebm.70046

LETTER

Variability and Advancements in ChatGPT Risk of Bias Assessments: A Replication and Comparative Analysis

Author information +

History +

PDF

Keywords

data extraction / large language models (LLMs) / risk of bias

Cite this article

Download citation ▾

Jules Descamps, Matthieu Resche-Rigon, Guillaume Draznieks, Cesar Quirino, Rémy Nizard, Pierre-Alban Bouché. Variability and Advancements in ChatGPT Risk of Bias Assessments: A Replication and Comparative Analysis. Journal of Evidence-Based Medicine, 2025, 18(2): e70046 DOI:10.1111/jebm.70046

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	U. Fischer, J. Kaesmacher, D. Strbian, et al., “Thrombectomy Alone Versus Intravenous Alteplase Plus Thrombectomy in Patients With Stroke: An Open-Label, Blinded-Outcome, Randomised Non-Inferiority Trial,” Lancet 400, no. 10346 (2022): 104-115.

[2]

L. P. Mcgarvey, S. S. Birring, A. H. Morice, et al., “Efficacy and Safety of Gefapixant, a P2×3 Receptor Antagonist, in Refractory Chronic Cough and Unexplained Chronic Cough (COUGH-1 and COUGH-2): Results From Two Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, Phase 3 Trials,” Lancet 399, no. 10328 (2022): 909-923.

[3]	P. J. Mitchell, B. Yan, L. Churilov, et al., “Endovascular Thrombectomy Versus Standard Bridging Thrombolytic With Endovascular Thrombectomy Within 4·5 h of Stroke Onset: An Open-Label, Blinded-Endpoint, Randomised Non-Inferiority Trial,” Lancet 400, no. 10346 (2022): 116-125.

[4]	K. Suzuki, Y. Matsumaru, M. Takeuchi, et al., “Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial,” JAMA 325, no. 3 (2021): 244.

[5]	W. Zi, Z. Qiu, F. Li, et al., “Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial,” JAMA 325, no. 3 (2021): 234.

[6]	L. Bertizzolo, P. Bossuyt, I. Atal, P. Ravaud, and A. Dechartres, “Disagreements in Risk of Bias Assessment for Randomised Controlled Trials Included in More Than One Cochrane Systematic Reviews: A Research on Research Study Using Cross-Sectional Design,” BMJ Open 9, no. 4 (2019): e028382.

[7]	F. Maleki and M. Karami, “Methodological Challenges for the Responsible Use of AI in Systematic Reviews: Risk of Bias Assessment,” Journal of Evidence-Based Medicine 17, no. 4 (2024): 712-713.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.